Literature DB >> 8938756

The mu-opioid receptor (MOR1) is mainly restricted to neurons that do not contain GABA or glycine in the superficial dorsal horn of the rat spinal cord.

T Kemp1, R C Spike, C Watt, A J Todd.   

Abstract

The mu-opioid receptor MOR1 is present on primary afferent axons and a population of neurons in the superficial dorsal horn of the rat spinal cord. In order to determine which types of neuron possess the receptor we carried out pre-embedding immunocytochemistry with antibody to MOR1 and combined this with a post-embedding method to detect GABA and glycine in the rat. MOR1 immunoreactivity was seen on many small neurons in lamina II and a few in the dorsal part of lamina III. Although immunostaining was mainly restricted to the cell bodies and dendrites of these neurons, in some cases it was possible to see their axons, and a few of these entered lamina III. One hundred and thirty-nine MOR1-immunoreactive cells were tested with GABA and glycine antibodies, and the great majority of these (131 of 139; 94%) were not GABA or glycine immunoreactive, while the remainder showed GABA but not glycine immunoreactivity. These results suggest that most of the cells in the superficial dorsal horn which possess MOR1 are excitatory interneurons. They support the hypothesis that part of the action of mu-opioid agonists, such as morphine, involves the inhibition of excitatory interneurons which convey input from nociceptors to neurons in the deep dorsal horn, thus interrupting the flow of nociceptive information through polysynaptic pathways in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8938756     DOI: 10.1016/0306-4522(96)00333-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  24 in total

1.  Mu opioid receptors in developing human spinal cord.

Authors:  S B Ray; S Wadhwa
Journal:  J Anat       Date:  1999-07       Impact factor: 2.610

2.  Actions of opioids on excitatory and inhibitory transmission in substantia gelatinosa of adult rat spinal cord.

Authors:  T Kohno; E Kumamoto; H Higashi; K Shimoji; M Yoshimura
Journal:  J Physiol       Date:  1999-08-01       Impact factor: 5.182

3.  Up-regulation of mu-opioid receptors in the spinal cord of morphine-tolerant rats.

Authors:  Subrata Basu Ray; Himanshu Gupta; Yogendra Kumar Gupta
Journal:  J Biosci       Date:  2004-03       Impact factor: 1.826

4.  Excitatory interneurons dominate sensory processing in the spinal substantia gelatinosa of rat.

Authors:  Sónia F A Santos; Sandra Rebelo; Victor A Derkach; Boris V Safronov
Journal:  J Physiol       Date:  2007-03-01       Impact factor: 5.182

5.  Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.

Authors:  Bingbing Song; Juan Carlos G Marvizón
Journal:  J Neurosci       Date:  2003-03-01       Impact factor: 6.167

Review 6.  Neuronal circuitry for pain processing in the dorsal horn.

Authors:  Andrew J Todd
Journal:  Nat Rev Neurosci       Date:  2010-11-11       Impact factor: 34.870

Review 7.  Transmitting pain and itch messages: a contemporary view of the spinal cord circuits that generate gate control.

Authors:  João Braz; Carlos Solorzano; Xidao Wang; Allan I Basbaum
Journal:  Neuron       Date:  2014-05-07       Impact factor: 17.173

8.  The glutamatergic nature of TRPV1-expressing neurons in the spinal dorsal horn.

Authors:  Hong-Yi Zhou; Shao-Rui Chen; Hong Chen; Hui-Lin Pan
Journal:  J Neurochem       Date:  2008-11-19       Impact factor: 5.372

9.  Dorsal horn neurons firing at high frequency, but not primary afferents, release opioid peptides that produce micro-opioid receptor internalization in the rat spinal cord.

Authors:  Bingbing Song; Juan Carlos G Marvizón
Journal:  J Neurosci       Date:  2003-10-08       Impact factor: 6.167

10.  Effects of endomorphin on substantia gelatinosa neurons in rat spinal cord slices.

Authors:  Su-Ying Wu; Yoshitaka Ohtubo; G Cristina Brailoiu; Nae J Dun
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.